Tisch MS Research Center of New York today announced encouraging preliminary results from its FDA-approved Phase I trial using autologous neural stem cells in the treatment of multiple sclerosis . MS is a chronic autoimmune disease of the central nervous system where the myelin sheath is attacked and neurodegeneration may occur.
http://ift.tt/1zQGdmr
No comments:
Post a Comment